NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,742 | +0.9% | 184 | 0.0% | 0.01% | -18.2% |
| Q2 2023 | $18,567 | +9.7% | 184 | 0.0% | 0.01% | +22.2% |
| Q1 2023 | $16,928 | +37.2% | 184 | +35.3% | 0.01% | +28.6% |
| Q4 2022 | $12,338 | -82.6% | 136 | -85.5% | 0.01% | -84.1% |
| Q3 2022 | $71,000 | -99.9% | 936 | 0.0% | 0.04% | -8.3% |
| Q2 2022 | $79,120,000 | +74541.5% | 936 | -22.6% | 0.05% | -29.4% |
| Q4 2021 | $106,000 | -42.1% | 1,209 | -46.2% | 0.07% | -34.0% |
| Q3 2021 | $183,000 | +59.1% | 2,247 | +85.7% | 0.10% | +12.0% |
| Q2 2021 | $115,000 | – | 1,210 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |